Furosemide and Docosahexanoic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Docosahexanoic acid (krill oil). Common drug interactions include coma among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Docosahexanoic acid. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Docosahexanoic acid?

Docosahexanoic acid has active ingredients of krill oil. eHealthMe is studying from 181 Docosahexanoic acid users. Check the latest studies of Docosahexanoic acid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 13, 2026

28 people who take Furosemide and Docosahexanoic acid together, and have interactions are studied.

Furosemide and Docosahexanoic acid drug interactions.

What are the common drug interactions of Furosemide and Docosahexanoic Acid, by gender? *:

female:

Coma (state of unconsciousness lasting more than six hours)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Somnolence (a state of near-sleep, a strong desire for sleep)
Chronic kidney disease
Diastolic dysfunction
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Muscular weakness (muscle weakness)
Obesity (having too much body fat)
Renal failure (kidney dysfunction)

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Abdominal pain upper
Acute myocardial infarction (acute heart attack)
Altered state of consciousness (altered state of mind)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Cardiac arrest
Cardiac failure

What are the common drug interactions of Furosemide and Docosahexanoic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Somnolence (a state of near-sleep, a strong desire for sleep)
Coma (state of unconsciousness lasting more than six hours)
Emotional distress
Fear
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Injury
Pain
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Stress

What are the existing conditions these people have? *

Pain: 12 people, 42.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Docosahexanoic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously